- The Flowr Corporation (FLWR) has completed its first shipment of premium cannabis from Canada to Israel
- This initial shipment consisted of two strains of Flowr’s premium cannabis, BC Black Cherry and BC Strawnana, for a total cost of $825,000
- Flowr expects to ship additional exports of its premium cannabis brands to Israel later in 2022
- The company also announced today that its subsidiary in Portugal expects to harvest at least 300 kilograms of indoor grown medical cannabis in Q1 2022.
- The Flowr Corporation is a Canadian cannabis company with operations in Canada and the European Union
- Shares in The Flowr Corporation (FLWR) are up 7.69 per cent, trading at $0.07 per share
The Flowr Corporation (FLWR) has completed its first shipment of premium cannabis from Canada to Israel.
As part of Flowr’s international supply agreement with Focus Medical Herbs, the shipment represents the company’s debut into the Israeli cannabis market and its first significant international export.
This initial shipment consisted of two strains of Flowr’s premium cannabis, BC Black Cherry and BC Strawnana, for a total cost of $825,000.
Flowr expects to ship additional exports of its premium cannabis brands to Israel later in 2022 as part of its three-year partnership with Focus Medical.
“We are extremely pleased to have completed our first shipment to Israel as part of our partnership with IMC and Focus Medical,” commented Flowr’s CEO Darryl Brooker. “As the Israeli medical cannabis industry continues to grow, we expect the market to be an important destination for us to grow our brand and distribution reach internationally.”
Flowr also announced today that in Portugal, its wholly-owned subsidiary Holigen Holdings Limited expects to harvest at least 300 kilograms of indoor-grown medical cannabis in the first quarter of 2022.
Holigen is in the final stages of cultivating BC Black Cherry and BC Strawnana strains and expects to commence harvesting at its purpose-built indoor facility in Sintra, Portugal by the end of January 2022.
“Our strategy in Portugal is appearing to pay dividends,” said Mr. Brooker. “We are very much looking forward to the near-term results in Portugal and see the E.U. as an under-valued and under-appreciated part of our business.”
The Flowr Corporation is a Canadian cannabis company with operations in Canada and the European Union.
Its Canadian operating campus, located in Kelowna, British Columbia, includes a purpose-built, GMP-designed indoor cultivation facility, an outdoor and greenhouse cultivation site, and a state-of-the-art R&D facility.
Shares in The Flowr Corporation (FLWR) are up 7.69 per cent, trading at $0.07 per share as of 10:35 am EST.
